Beam Therapeutics
BEAM
$21.38
Share price
-1.02%
Change (1 day)
-30.38%
Change (1 year)
Operating Margin for Beam Therapeutics (BEAM)
Operating Margin as of April 2024 (TTM): -470.92%
According to Beam Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -470.92%. At the end of 2022 the company had an Operating Margin of -427.08%.
Operating Margin history for Beam Therapeutics from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -427.08% | -40.26% |
| 2021 | -714.91% | -99.91% |
| 2020 | -810,800.00% | 86.33% |
| 2019 | -435,144.44% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.